CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade DarioHealth Corp. - DRIO CFD

    1.87
    18.35%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.05
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026346 %
    Charges from full value of position ($-5.01)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026346%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.004124 %
    Charges from full value of position ($0.78)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.004124%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    DarioHealth Corp ESG Risk Ratings

    High Medium Low Negligible

    ‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 1.58
    Open* 1.64
    1-Year Change* -66.39%
    Day's Range* 1.54 - 1.87
    52 wk Range 0.68-6.78
    Average Volume (10 days) 116.10K
    Average Volume (3 months) 3.66M
    Market Cap 28.30M
    P/E Ratio -100.00K
    Shares Outstanding 27.21M
    Revenue 23.55M
    EPS -2.20
    Dividend (Yield %) N/A
    Beta 1.38
    Next Earnings Date Mar 7, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Dec 4, 2023 1.58 0.22 16.18% 1.36 1.60 1.36
    Dec 1, 2023 1.38 0.24 21.05% 1.14 1.39 1.14
    Nov 30, 2023 1.19 -0.05 -4.03% 1.24 1.26 1.15
    Nov 29, 2023 1.27 0.23 22.12% 1.04 1.28 1.04
    Nov 28, 2023 1.02 -0.03 -2.86% 1.05 1.07 1.00
    Nov 27, 2023 1.06 0.02 1.92% 1.04 1.09 1.02
    Nov 24, 2023 1.03 0.04 4.04% 0.99 1.04 0.97
    Nov 22, 2023 0.98 -0.03 -2.97% 1.01 1.03 0.98
    Nov 21, 2023 1.02 -0.08 -7.27% 1.10 1.10 1.02
    Nov 20, 2023 1.11 -0.19 -14.62% 1.30 1.30 1.09
    Nov 17, 2023 1.17 0.18 18.18% 0.99 1.20 0.99
    Nov 16, 2023 0.99 0.00 0.00% 0.99 1.02 0.99
    Nov 15, 2023 1.02 0.05 5.15% 0.97 1.07 0.97
    Nov 14, 2023 1.00 -0.04 -3.85% 1.04 1.06 0.99
    Nov 13, 2023 1.01 -0.02 -1.94% 1.03 1.05 0.96
    Nov 10, 2023 1.04 0.02 1.96% 1.02 1.11 1.02
    Nov 9, 2023 1.06 -0.13 -10.92% 1.19 1.19 1.05
    Nov 8, 2023 1.17 -0.09 -7.14% 1.26 1.27 1.15
    Nov 7, 2023 1.29 -0.02 -1.53% 1.31 1.33 1.24
    Nov 6, 2023 1.29 -0.05 -3.73% 1.34 1.40 1.27

    DarioHealth Corp. Events

    Time (UTC) Country Event
    Thursday, December 7, 2023

    Time (UTC)

    14:00

    Country

    IL

    Event

    DarioHealth Corp Annual Shareholders Meeting
    DarioHealth Corp Annual Shareholders Meeting

    Forecast

    -

    Previous

    -
    Monday, December 11, 2023

    Time (UTC)

    14:00

    Country

    IL

    Event

    DarioHealth Corp Annual Shareholders Meeting
    DarioHealth Corp Annual Shareholders Meeting

    Forecast

    -

    Previous

    -
    Thursday, March 7, 2024

    Time (UTC)

    13:30

    Country

    IL

    Event

    Q4 2023 DarioHealth Corp Earnings Release
    Q4 2023 DarioHealth Corp Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 27.656 20.513 7.576 7.559 7.394
    Revenue 27.656 20.513 7.576 7.559 7.394
    Cost of Revenue, Total 18.001 16.55 5.063 4.962 5.629
    Gross Profit 9.655 3.963 2.513 2.597 1.765
    Total Operating Expense 88.931 97.007 37.479 25.264 25.082
    Selling/General/Admin. Expenses, Total 46.816 63.238 27.983 16.61 15.777
    Research & Development 19.649 17.219 4.433 3.692 3.676
    Unusual Expense (Income) 4.465
    Operating Income -61.275 -76.494 -29.903 -17.705 -17.688
    Interest Income (Expense), Net Non-Operating -0.107 -0.151 0.507 -0.004 -0.115
    Other, Net -0.807 -0.084 -0.049 -0.027
    Net Income Before Taxes -62.189 -76.729 -29.445 -17.736 -17.803
    Net Income After Taxes -62.193 -76.761 -29.445 -17.736 -17.803
    Net Income Before Extra. Items -62.193 -76.761 -29.445 -17.736 -17.803
    Net Income -62.193 -76.761 -29.445 -17.736 -17.803
    Total Adjustments to Net Income -1.643 -2.005 -3.658 -3.155 -0.493
    Income Available to Common Excl. Extra. Items -63.836 -78.766 -33.103 -20.891 -18.296
    Income Available to Common Incl. Extra. Items -63.836 -78.766 -33.103 -20.891 -18.296
    Diluted Net Income -63.836 -78.766 -33.103 -20.891 -18.296
    Diluted Weighted Average Shares 23.635 16.5917 5.96331 2.26614 1.17064
    Diluted EPS Excluding Extraordinary Items -2.70091 -4.74731 -5.55112 -9.21878 -15.629
    Diluted Normalized EPS -2.57811 -4.71283 -5.55112 -9.21878 -15.629
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 6.152 7.066 6.809 6.605 6.183
    Revenue 6.152 7.066 6.809 6.605 6.183
    Cost of Revenue, Total 4.078 3.898 4.077 4.805 5.045
    Gross Profit 2.074 3.168 2.732 1.8 1.138
    Total Operating Expense 23.839 19.263 19.155 22.316 23.529
    Selling/General/Admin. Expenses, Total 10.872 10.411 6.96 11.57 14.356
    Research & Development 5.222 5.165 4.782 4.803 4.137
    Operating Income -17.687 -12.197 -12.346 -15.711 -17.346
    Interest Income (Expense), Net Non-Operating 1.621 -0.579 -0.244 0.093 0.062
    Other, Net -0.519 -0.049 -0.024 -0.014 -0.743
    Net Income Before Taxes -16.585 -12.825 -12.614 -15.632 -18.027
    Net Income After Taxes -16.585 -12.825 -12.617 -15.632 -18.028
    Net Income Before Extra. Items -16.585 -12.825 -12.617 -15.632 -18.028
    Net Income -16.585 -12.825 -12.617 -15.632 -18.028
    Total Adjustments to Net Income -1.691 0 -0.265 -0.494 -0.433
    Income Available to Common Excl. Extra. Items -18.276 -12.825 -12.882 -16.126 -18.461
    Income Available to Common Incl. Extra. Items -18.276 -12.825 -12.882 -16.126 -18.461
    Diluted Net Income -18.276 -12.825 -12.882 -16.126 -18.461
    Diluted Weighted Average Shares 28.1863 27.57 25.911 22.9732 22.426
    Diluted EPS Excluding Extraordinary Items -0.6484 -0.46518 -0.49716 -0.70195 -0.8232
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.5183 -0.47283 -0.41348 -0.65241 -0.82346
    Unusual Expense (Income) 3.667 -0.211 3.336 1.138 -0.009
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 65.524 45.605 34.128 22.939 13.313
    Cash and Short Term Investments 49.522 36 28.777 20.586 11.177
    Cash & Equivalents 49.357 35.808 28.59 20.395 10.997
    Short Term Investments 0.165 0.192 0.187 0.191 0.18
    Total Receivables, Net 6.899 1.71 1.624 0.672 0.759
    Accounts Receivable - Trade, Net 6.416 1.31 0.124 0.672 0.168
    Total Inventory 7.956 6.228 2.293 1.414 1.377
    Prepaid Expenses 0.908 1.591 1.354 0.203
    Other Current Assets, Total 0.239 0.076 0.08 0.064
    Total Assets 119.191 100.771 35.407 24.569 14.089
    Property/Plant/Equipment, Total - Net 1.994 0.989 1.074 1.413 0.733
    Property/Plant/Equipment, Total - Gross 3.433 2.215 1.866 2.024
    Accumulated Depreciation, Total -1.439 -1.226 -0.792 -0.611
    Other Long Term Assets, Total 0.117 0.077 0.205 0.217 0.043
    Total Current Liabilities 19.35 14.376 7.034 5.22 5.164
    Accounts Payable 2.322 5.109 2.48 1.656 2.574
    Accrued Expenses 6.885 8.072 3.33 2.341
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 1.32 1.195 1.224 1.223 2.59
    Total Liabilities 39.192 15.222 7.256 5.675 5.164
    Total Long Term Debt 18.105 0 0 0 0
    Long Term Debt 18.105
    Other Liabilities, Total 1.737 0.846 0.222 0.455 0
    Total Equity 79.999 85.549 28.151 18.894 8.925
    Preferred Stock - Non Redeemable, Net 0 0 0 0
    Common Stock 0.003 0.002 0.00081 0.00022 0.008
    Additional Paid-In Capital 365.846 307.561 171.399 129.039 98.171
    Retained Earnings (Accumulated Deficit) -285.85 -222.014 -143.248 -110.145 -89.254
    Total Liabilities & Shareholders’ Equity 119.191 100.771 35.407 24.569 14.089
    Total Common Shares Outstanding 25.7245 16.5734 8.11949 2.23565 1.83039
    Total Preferred Shares Outstanding 0.00357 0.01193 0.01582 0 0
    Other Equity, Total -0.00081 -0.00022
    Goodwill, Net 41.64 41.64
    Intangibles, Net 9.916 12.46
    Current Port. of LT Debt/Capital Leases 8.823
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 56.211 65.777 55.476 65.524 71.582
    Cash and Short Term Investments 44.273 52.995 43.318 49.522 57.257
    Cash & Equivalents 43.878 52.602 38.789 49.357 57.081
    Short Term Investments 0.395 0.393 4.529 0.165 0.176
    Total Receivables, Net 6.467 6.868 5.281 8.046 6.563
    Accounts Receivable - Trade, Net 4.533 4.821 2.797 6.416 4.521
    Total Inventory 5.471 5.914 6.877 7.956 7.762
    Total Assets 106.505 117.159 108.009 119.191 126.334
    Property/Plant/Equipment, Total - Net 1.977 1.888 1.935 1.994 2.032
    Goodwill, Net 41.64 41.64 41.64 41.64 41.64
    Intangibles, Net 6.541 7.678 8.803 9.916 11.053
    Other Long Term Assets, Total 0.136 0.176 0.155 0.117 0.027
    Total Current Liabilities 8.106 8.076 17.617 19.35 11.524
    Accounts Payable 1.929 1.451 1.883 2.322 1.982
    Accrued Expenses 0.119 0.145 0.291 0.293 0.27
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 0.684 0.789 0.925 1.32 2.76
    Total Liabilities 38.47 38.755 35.979 39.192 37.388
    Total Long Term Debt 29 29.094 16.745 18.105 24.046
    Other Liabilities, Total 1.364 1.585 1.617 1.737 1.818
    Total Equity 68.035 78.404 72.03 79.999 88.946
    Preferred Stock - Non Redeemable, Net
    Common Stock 0.003 0.003 0.003 0.003 0.002
    Additional Paid-In Capital 401.887 395.352 370.702 365.846 361.912
    Retained Earnings (Accumulated Deficit) -333.855 -316.951 -298.675 -285.85 -272.968
    Other Equity, Total
    Total Liabilities & Shareholders’ Equity 106.505 117.159 108.009 119.191 126.334
    Total Common Shares Outstanding 27.2152 26.7847 25.8753 25.7245 23.291
    Total Preferred Shares Outstanding 0.01896 0.01896 0.00356 0.00357 0.00991
    Payable/Accrued 5.374 5.691 5.935 6.592 6.512
    Long Term Debt 29 29.094 16.745 18.105 24.046
    Current Port. of LT Debt/Capital Leases 0 8.583 8.823
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -62.193 -76.761 -29.445 -17.736 -17.803
    Cash From Operating Activities -47.845 -50.409 -17.736 -15.725 -11.47
    Cash From Operating Activities 0.356 0.282 0.19 0.183 0.207
    Non-Cash Items 20.108 26.322 11.369 2.625 3.758
    Changes in Working Capital -10.477 -3.287 0.15 -0.797 2.368
    Cash From Investing Activities -0.573 -8.134 -1.622 -0.113 0.006
    Capital Expenditures -0.573 -0.261 -0.118 -0.098 -0.071
    Other Investing Cash Flow Items, Total 0 -7.873 -1.504 -0.015 0.077
    Cash From Financing Activities 61.94 65.766 27.548 25.247 18.743
    Issuance (Retirement) of Stock, Net 38.154 65.766 27.548 25.247 18.743
    Net Change in Cash 13.522 7.223 8.19 9.409 7.279
    Amortization 4.361 3.035
    Cash Interest Paid 1.876
    Issuance (Retirement) of Debt, Net 23.786
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -12.825 -62.193 -49.576 -33.944 -15.916
    Cash From Operating Activities -4.757 -47.845 -39.904 -29.209 -18.094
    Cash From Operating Activities 0.097 0.356 0.243 0.154 0.07
    Amortization 1.113 4.361 3.224 2.087 0.963
    Non-Cash Items 4.585 20.108 13.818 9.303 5.35
    Changes in Working Capital 2.273 -10.477 -7.613 -6.809 -8.561
    Cash From Investing Activities -4.362 -0.573 -0.514 -0.34 -0.181
    Capital Expenditures -0.074 -0.573 -0.514 -0.34 -0.181
    Other Investing Cash Flow Items, Total -4.288 0 0 0 0
    Cash From Financing Activities -1.389 61.94 61.675 61.675 38.023
    Issuance (Retirement) of Stock, Net 38.154 37.889 37.889 38.023
    Net Change in Cash -10.508 13.522 21.257 32.126 19.748
    Cash Interest Paid 1.072 1.876 0.969 0.181
    Issuance (Retirement) of Debt, Net -1.389 23.786 23.786 23.786
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Nantahala Capital Management, LLC Hedge Fund 8.8854 2418507 0 2023-06-30 MED
    Phoenix Investment and Finances Ltd Investment Advisor 4.9268 1341027 0 2023-06-30 MED
    More Investment House Ltd. Investment Advisor/Hedge Fund 4.7339 1288518 -178202 2023-09-30 LOW
    Appian Way Asset Management LP Investment Advisor/Hedge Fund 4.7069 1281158 258376 2023-06-30 HIGH
    Clal Insurance Enterprises Holdings Ltd. Investment Advisor 3.9185 1066561 0 2023-06-30 LOW
    Kershner Trading Americas, L.L.C. Corporation 3.8687 1053024 -180500 2023-09-08 LOW
    Raphael (Erez) Individual Investor 2.9484 802521 91777 2023-03-03 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 1.0601 288549 0 2023-06-30 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.9188 250099 55704 2023-06-30 LOW
    Ben-David (Zvi) Individual Investor 0.9139 248765 26455 2023-03-03 LOW
    Stern (Adam K.) Individual Investor 0.6526 177634 122026 2023-03-03 MED
    Bacher (Dror) Individual Investor 0.6229 169533 40515 2023-03-03 MED
    Shaked (Yoav) Individual Investor 0.441 120042 9102 2023-03-03 LOW
    MAI Capital Management, LLC Investment Advisor/Hedge Fund 0.3946 107394 -38406 2023-06-30 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 0.3887 105800 -37187 2023-06-30 LOW
    Shay Capital LLC Hedge Fund 0.3674 100000 0 2023-06-30 HIGH
    LPL Financial LLC Investment Advisor 0.3391 92301 5735 2023-06-30 LOW
    Karah (Hila) Individual Investor 0.3095 84255 10025 2023-03-03 MED
    Matheis (Dennis) Individual Investor 0.282 76747 -29127 2023-03-03 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.248 67497 0 2023-06-30 LOW

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    DarioHealth Corp. Company profile

    About DarioHealth Corp

    DarioHealth Corp.(DarioHealth) is a Digital Therapeutics (DTx) company. DarioHealth operates at the intersection of life sciences, behavioral science, and software technology to deliver integrated and engaging digital therapeutics interventions. DarioHealth offers digital therapeutics solutions covering multiple chronic conditions including diabetes, hypertension, weight management, musculoskeletal and behavioral health within one integrated technology platform. DarioHealth products include Dario blood glucose monitoring, Dario Blood Pressure Monitoring System, and Dario Smart Scale. The Dario blood glucose monitoring device is a system that measure sugar levels. The Dario Smart Scale is a blood pressure monitoring system used to measure blood pressure and stored in a digital logbook in the Dario App. It offers modular platform integrating digital therapeutics, coaching, devices, and care providers. Its suite of offerings includes Dario Tools, DarioEngage, and Dario Loop.

    Financial summary

    BRIEF: For the fiscal year ended 31 December 2021, DarioHealth Corp revenues increased from $7.6M to $20.5M. Net loss applicable to common stockholders increased from $33.1M to $78.8M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Marketing and Pre-Production Cost increase from $12.5M to $33.7M (expense).

    Equity composition

    Common Stock $0.0001 Par, Shares auth. 45M and o/s 19,240,234 issd. Insiders own approx. 14.03% (after the IPO). If no information is provided, use TBA. 10/14 1-for-5 reverse stock split. 03/2016, 1-For-18 Reverse Stock Split.

    Industry: Medical Equipment, Supplies & Distribution (NEC)

    18 W 18Th St., 5Th Floor
    NEW YORK
    NEW YORK 10011
    US

    Income Statement

    • Annual
    • Quarterly

    News

    December RBA preview: no move expected at the final meeting of 2023

    The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

    14:47, 4 December 2023

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023

    People also watch

    BTC/USD

    43,910.70 Price
    +4.020% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    Oil - Crude

    72.63 Price
    -0.890% 1D Chg, %
    Long position overnight fee -0.0224%
    Short position overnight fee 0.0005%
    Overnight fee time 22:00 (UTC)
    Spread 0.030

    XRP/USD

    0.63 Price
    -0.280% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    US100

    15,847.00 Price
    +0.150% 1D Chg, %
    Long position overnight fee -0.0263%
    Short position overnight fee 0.0041%
    Overnight fee time 22:00 (UTC)
    Spread 1.8

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading